News & Perspective

Jun 27, 2017

Jun 27, 2017

News Scan for Jun 27, 2017

Antibiotic resistance at the Hajj
MERS in Riyadh
Plague cases
Cat-linked tularemia case
HPV vaccine impact
H5N8 in Belgium

May 10, 2017

May 10, 2017

News Scan for May 10, 2017

MRSA bacteremia
WHO on Liberia probe
Zika vaccine trial
Senate confirms FDA head
Tularemia in Australia

Aug 30, 2010

Aug 30, 2010

HHS funds development of drug for plague, tularemia

(CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded a contract to a San Francisco company to further the development of a new broad-spectrum antibiotic for treating plague, tularemia, and various resistant infections.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»